Literature DB >> 16568367

Minimal changes in reflux esophagitis: red ones and white ones.

Michio Hongo1.   

Abstract

Minimal change esophagitis is commonly accepted as part of the spectrum of reflux esophagitis in Japan as well as in many reflux esophagitis classification systems. However, the Los Angeles system excludes minimal changes as a sign of reflux esophagitis because of low interobserver agreement. The high prevalence of minimal change esophagitis suggests that many endoscopists can recognize such findings in their patients' esophagi. However, we do not have a clear definition of minimal changes, which requires proven interobserver agreement, histological evidence, and response data to therapeutic intervention. Furthermore, erythematous changes (red ones) and acanthotic changes (white ones) are not distinguished in the definition of minimal change used in Japan. It is time to clarify such issues.

Entities:  

Mesh:

Year:  2006        PMID: 16568367     DOI: 10.1007/s00535-006-1775-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy.

Authors:  S Nandurkar; N J Talley; C J Martin; T Ng; S Adams
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

2.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

3.  Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

Authors:  C M Bate; P W Keeling; C O'Morain; S P Wilkinson; D N Foster; R A Mountford; J M Temperley; R F Harvey; D G Thompson; M Davis
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

Authors:  D J Hetzel; J Dent; W D Reed; F M Narielvala; M Mackinnon; J H McCarthy; B Mitchell; B R Beveridge; B H Laurence; G G Gibson
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

5.  Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.

Authors:  Ichiro Yoshikawa; Masahiro Yamasaki; Takuji Yamasaki; Keiichiro Kume; Makoto Otsuki
Journal:  Gastrointest Endosc       Date:  2005-11       Impact factor: 9.427

6.  Is there a set of histologic changes that are invariably reflux associated?

Authors:  Kaiyo Takubo; Naoko Honma; Gopi Aryal; Motoji Sawabe; Tomio Arai; Yasuo Tanaka; Ken-ichi Mafune; Katsuhiko Iwakiri
Journal:  Arch Pathol Lab Med       Date:  2005-02       Impact factor: 5.534

7.  Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease.

Authors:  N E Schindlbeck; B Wiebecke; A G Klauser; W A Voderholzer; S A Müller-Lissner
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment.

Authors:  A Sonnenberg; G Lepsien; S A Müller-Lissner; H R Koelz; J R Siewert; A L Blum
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

9.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis.

Authors:  P Bytzer; T Havelund; J M Hansen
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

Review 10.  [Endoscopic findings of GERD].

Authors:  Yoshio Hoshihara
Journal:  Nihon Rinsho       Date:  2004-08
View more
  53 in total

1.  Cardiac mucosa at the gastroesophageal junction: An Eastern perspective.

Authors:  Ahrong Kim; Won-Young Park; Nari Shin; Hyun Jung Lee; Young Keum Kim; So Jeong Lee; Cheong-Soo Hwang; Do Youn Park; Gwang Ha Kim; Bong Eun Lee; Hong-Jae Jo
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  Validity of endoscopic classification of nonerosive reflux disease.

Authors:  Takashi Joh; Hiroto Miwa; Kazuhide Higuchi; Tomohiko Shimatani; Noriaki Manabe; Kyoichi Adachi; Tsuneya Wada; Makoto Sasaki; Yasuhiro Fujiwara; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  Key points in the management of gastroesophageal reflux disease.

Authors:  Fabio Baldi
Journal:  Curr Gastroenterol Rep       Date:  2007-03

4.  Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.

Authors:  Kiyoshi Ashida; Yoshikazu Kinoshita; Michio Hongo
Journal:  Dig Dis Sci       Date:  2011-02-08       Impact factor: 3.199

5.  Roux-en-Y reconstruction is superior to billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of his.

Authors:  Tsutomu Namikawa; Hiroyuki Kitagawa; Takehiro Okabayashi; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

6.  Double tract reconstruction after distal gastrectomy for gastric cancer is effective in reducing reflux esophagitis and remnant gastritis with duodenal passage preservation.

Authors:  Tsutomu Namikawa; Hiroyuki Kitagawa; Takehiro Okabayashi; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2011-03-30       Impact factor: 3.445

7.  Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.

Authors:  Nobuyuki Matsuhashi; Mineo Kudo; Norimasa Yoshida; Kazunari Murakami; Mototsugu Kato; Tsuyoshi Sanuki; Atsushi Oshio; Takashi Joh; Kazuhide Higuchi; Ken Haruma; Koji Nakada
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

8.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Authors:  Takahisa Furuta; Tomohiko Shimatani; Mitsushige Sugimoto; Shunji Ishihara; Yasuhiro Fujiwara; Motoyasu Kusano; Tomoyuki Koike; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

9.  Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.

Authors:  Takayoshi Suzuki; Masashi Matsushima; Aya Masui; Shingo Tsuda; Jin Imai; Jun Nakamura; Yoko Tsukune; Tetsufumi Uchida; Hiroki Yuhara; Muneki Igarashi; Jun Koike; Tetsuya Mine
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

10.  The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome.

Authors:  Hyun Joo Song; Ki-Nam Shim; Su Jin Yoon; Seong-Eun Kim; Hee Jung Oh; Kum Hei Ryu; Chang Yoon Ha; Hye Jung Yeom; Ji Hyun Song; Sung-Ae Jung; Kwon Yoo
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.